Applied Therapeutics, Inc.
APLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $119 | $282 | $29 | $229 |
| - Cash | $79 | $50 | $17 | $54 |
| + Debt | $3 | $1 | $2 | $2 |
| Enterprise Value | $43 | $233 | $14 | $177 |
| Revenue | $0 | $10 | $0 | $0 |
| % Growth | -95.4% | – | – | – |
| Gross Profit | -$48 | -$44 | -$0 | $0 |
| % Margin | -10,613% | -439.4% | – | – |
| EBITDA | -$104 | -$65 | -$82 | -$106 |
| % Margin | -22,922.6% | -645.8% | – | – |
| Net Income | -$106 | -$120 | -$83 | -$106 |
| % Margin | -23,214.1% | -1,198.5% | – | – |
| EPS Diluted | -0.76 | -1.42 | -2.18 | -4.12 |
| % Growth | 46.5% | 34.9% | 47.1% | – |
| Operating Cash Flow | -$84 | -$55 | -$78 | -$91 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$84 | -$55 | -$78 | -$91 |